Phase 3 Study of MRTX849 in Lung Cancer
A Randomized Phase 3 Study of MRTX849 versus Docetaxel in Patients with Previously Treated Non-Small Cell Lung Cancer with KRAS G12C Mutation
Disease Types: Lung
Available at: Alleghany, Blacksburg, Roanoke, Salem, Wytheville
For more information: